Transgenic swine: Expression of human CD39 protects against myocardial injury

Journal of Molecular and Cellular Cardiology

Volumn 52, Issue 5, 2012, Pages 958-961

  Wheeler, Debra G ^a   Joseph, Matthew E ^a   Mahamud, Shouvik D ^a   Aurand, William L ^a   Mohler, Peter J ^a,b   Pompili, Vincent J ^a   Dwyer, Karen M ^c,d   Nottle, Mark B ^f   Harrison, Sharon J ^f   d'Apice, Anthony J F ^c,d   Robson, Simon C ^e   Cowan, Peter J ^c,d   Gumina, Richard J ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c ST VINCENT S HOSPITAL   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^f UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

CD39; Ectonucleoside triphosphate diphosphohydrolase 1; Myocardial ischemia; Reperfusion; Transgenic pig

Indexed keywords

CD39 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL NUCLEUS TRANSPLANTATION; CONTROLLED STUDY; ENZYME ACTIVITY; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PERFUSION; HEART PROTECTION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; SOMATIC CELL; SWINE; TISSUE LEVEL; TRANSGENIC ANIMAL; VALIDATION STUDY;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIGENS, CD; APYRASE; BLOOD PRESSURE; CORONARY VESSELS; HEART RATE; HEART VENTRICLES; HUMANS; ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; PROMOTER REGIONS, GENETIC; RECOMBINANT PROTEINS; SWINE;

ANIMALIA; MURINAE; MUS MUSCULUS; SUIDAE;

EID: 84859640267     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2012.01.002     Document Type: Article

References (15)

1. Roger V.L., Go A.S., Lloyd-Jones D.M., Adams R.J., Berry J.D., Brown T.M., et al. Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011, 123:e18-e209.
2. Kreissl M.C., Wu H.-M., Stout D.B., Ladno W., Schindler T.H., Zhang X., et al. Noninvasive measurement of cardiovascular function in mice with high-temporal-resolution small-animal PET. J Nucl Med 2006, 47:974-980.
3. Kohler D., Eckle T., Faigle M., Grenz A., Mittelbronn M., Laucher S., et al. CD39/ectonucleoside triphosphate diphosphohydrolase 1 provides myocardial protection during cardiac ischemia/reperfusion injury. Circulation 2007, 116:1784-1794.
4. Eckle T., Krahn T., Grenz A., Kohler D., Mittelbronn M., Ledent C., et al. Cardioprotection by ecto-5'-nucleotidase (CD73) and A2B adenosine receptors. Circulation 2007, 115:1581-1590.
5. Robson S.C., Wu Y., Sun X., Knosalla C., Dwyer K., Enjyoji K. Ectonucleotidases of CD39 family modulate vascular inflammation and thrombosis in transplantation. Semin Thromb Hemost 2005, 31:217-233.
6. Cai M., Huttinger Z.M., He H., Zhang W., Li F., Goodman L.A., et al. Transgenic over expression of ectonucleotide triphosphate diphosphohydrolase-1 protects against murine myocardial ischemic injury. J Mol Cell Cardiol 2011, 51:927-935.
7. Dwyer K.M., Robson S.C., Nandurkar H.H., Campbell D.J., Gock H., Murray-Segal L.J., et al. Thromboregulatory manifestations in human CD39 transgenic mice and the implications for thrombotic disease and transplantation. J Clin Invest 2004, 113:1440-1446.
8. Faast R., Harrison S.J., Beebe L.F., McIlfatrick S.M., Ashman R.J., Nottle M.B. Use of adult mesenchymal stem cells isolated from bone marrow and blood for somatic cell nuclear transfer in pigs. Cloning Stem Cells 2006, 8:166-173.
9. van der Pals J., Koul S., Gotberg M., Olivecrona G., Ugander M., Kanski M., et al. Apyrase treatment of myocardial infarction according to a clinically applicable protocol fails to reduce myocardial injury in a porcine model. BMC Cardiovasc Disord 2010, 10:1.
10. Eltzschig H.K., Ibla J.C., Furuta G.T., Leonard M.O., Jacobson K.A., Enjyoji K., et al. Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium. J Exp Med 2003, 198:783-796.
11. Liao H., Hyman M.C., Baek A.E., Fukase K., Pinsky D.J. cAMP/CREB-mediated transcriptional regulation of ectonucleoside triphosphate diphosphohydrolase 1 (CD39) expression. J Biol Chem 2010, 285:14791-14805.
12. Eltzschig H.K., Kohler D., Eckle T., Kong T., Robson S.C., Colgan S.P. Central role of Sp1-regulated CD39 in hypoxia/ischemia protection. Blood 2009, 113:224-232.
13. Friedman D.J., Kunzli B.M., YI A.R., Sevigny J., Berberat P.O., Enjyoji K., et al. CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease. Proc Natl Acad Sci U S A 2009, 106:16788-16793.
14. Heusch G., Skyschally A., Schulz R. The in-situ pig heart with regional ischemia/reperfusion-ready for translation. J Mol Cell Cardiol 2011, 50:951-963.
15. Lefer D.J., Bolli R. Development of an NIH Consortium for PreclinicAl AssESsment of CARdioprotective therapies (CAESAR). J Cardiovasc Pharmacol Ther 2011, 16:332-339.